Ionis pharma director Loscalzo sells $82k in shares

2026-03-06 08:56:34

Abstract generation in progress

Ionis Pharmaceuticals director Joseph Loscalzo sold 1,032 shares of common stock for approximately $82,832 and exercised options to acquire the same number of shares for $39,277. The company, which has a market cap of $12.44 billion, has seen its stock surge 122.7% over the past year despite profitability challenges. Ionis is also advancing with a supplemental New Drug Application for olezarsen and presenting new data on DAWNZERA, while analysts have adjusted price targets based on recent updates and upcoming clinical readouts.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes